This is topic EFSF>>>Citroxin O2 Ingestible Kills Avian Influenza in Independent Laboratory Testing in forum Micro Penny Stocks, Penny Stocks $0.10 & Under at Allstocks.com's Bulletin Board.


To visit this topic, use this URL:
http://www.allstocks.com/stockmessageboard/ubb/ultimatebb.php/ubb/get_topic/f/8/t/018679.html

Posted by Prdponce on :
 
eFoodSafety.com, Inc. Subsidiary, Knock-Out Technologies, Ltd.'s Citroxin O2 Ingestible Kills Avian Influenza in Independent Laboratory Testing; Bucks County Clinical Research Begins Testing on Influenza A and B


Business Editors / Health Editors

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 31, 2006--
Robert Bowker, President/CEO of Knock-Out Technologies,
Ltd., a wholly owned subsidiary of eFoodSafety.com, Inc. (OTCBB: EFSF)
announced today that Human Clinical Trials on Citroxin O2 ingestible
have commenced.
In independent laboratory testing, Citroxin O2 killed a strain of
the Avian Influenza Virus. Bucks County Clinical Research, Inc.,
(BCCR) (http://bccrinc.com/), an FDA clinical facility begins testing
on Influenza A and B Viruses to substantiate results. The tests are to
be conducted under the direction of David J. Miller, D.O., FAAP,
Executive Director of BCCR and Richard M. Goldfarb, M.D., FACS,
Medical Director of Research & Development of BCCR, a Director of
eFoodSafety.com, Inc., and President of MedElite, Inc., a wholly-owned
subsidiary of eFoodSafety.com, Inc.
After 100% successful eradication of a strain of Avian Influenza
Virus in laboratory testing, Knock-Out Technologies will seek to
impact in the clinical setting a reduction in severity and length of
time influenza virus will affect the human population. Since Avian
Influenza Virus cannot be studied in human subjects, we will set out
to show the efficacy in the treatment of Influenza Viruses A and B,
which mirror the Avian Influenza Virus.
"This milestone of testing with Human Clinical Trials with our
Citroxin O2 ingestible product will enable us to prove what our
laboratory findings have demonstrated. This further allows us as a
company, and for the benefit of our shareholders, a product that can
be revolutionary in the challenge of the worrisome Avian Influenza
Virus," stated Patricia-Ross Gruden, President/CEO of eFoodSafety.com,
Inc.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health
conditions around the world through its innovative technologies. The
company's Knock-Out Technologies, Ltd. subsidiary has developed an
environmentally safe sporicidal product formulated entirely of
food-grade components that eradicates anthrax and a germicidal product
that kills six major bacteria: E-coli, Listeria, Pseudomonas,
Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and
Black Mold. The sporicidal product has completed its final efficacy
laboratory study requisite for EPA registration. In the study, it
eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100%
efficacy on both hard and porous surfaces. The company's MedElite,
Inc. subsidiary distributes clinically proven products to physicians
who then prescribe the products for their patients. It is the
exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar
Cream that has been clinically proven to facilitate and improve the
appearance, redness and strength of scars (www.talsyn.com). The
company is also is a distributor for Cinnergen(TM), a non-prescription
liquid whole food nutritional supplement that promotes healthy glucose
metabolism (www.cinnergen.com), and most recently became a distributor
for Trimmendous(TM), a weight loss formula focusing on the body's
24-hour metabolic processes.
 
Posted by jununi on :
 
Any recommendation on EFSF?
Thanks

Received this info in ChartAdvisor newsletter...
--------------------------------
Ground Floor Profit Opportunity from
Konrad Kuhn, Editor and Publisher of
The KonLin Letter :

Feds Approve Breakthrough for Avian Flu Crisis

Breaking news:

EPA approves eFoodSafety Big Six Plus germicidal (Citroxin), a non-toxic spray that kills bird flu virus surrogate!

Non-toxic formula proven safe for broadscale uses.

Human trials are now underway to test efficacy in infected patients for Influenza A and B.

Agricultural use could soon stop worldwide bird flu pandemic.


Company: eFoodSafety
Symbol: EFSF

First Target: $2
Strategy: Buy and hold for sell signal from The KonLin Letter

Recommendation:
Immediate BUY NOW!

This is a high risk investment suitable only for aggressive investors. Please limit your investment to an amount you are comfortable putting at risk for loss.
 


© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2